GOSS
Gossamer Bio Inc
10.90$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.3% | -16.8% | +44.0% | -6.0% | -10.1% | -11.0% | -14.1% | -13.3% | -17.5% | -25.2% | -40.4% | |
| – | -10.2% | -16.7% | +45.3% | -7.2% | -10.0% | -11.1% | -14.4% | -13.5% | -17.8% | -25.7% | -41.6% | |
| – | -61.1% | +21.0% | +123.5% | -67.2% | +61.9% | -37.0% | -9.3% | -66.0% | +322.4% | +8.7% | +0.3% | |
| – | -9.9% | -17.6% | +45.0% | -7.7% | -9.9% | -12.4% | -17.5% | -15.4% | -24.0% | -27.5% | -42.5% | |
| – | – | – | – | +81.5% | -19.0% | +23.3% | +21.2% | +20.9% | +29.9% | -25.3% | -34.8% | |
| – | +2.4% | -6.6% | +25.5% | +1.7% | -3.7% | +0.4% | +0.1% | +1.4% | +1.3% | -1.6% | -41.1% | |
| – | +21.9% | -30.6% | +26.1% | +13.1% | -11.9% | +7.1% | +11.1% | +15.9% | +2.1% | -10.9% | +143.8% | |
| – | +0.6% | -18.0% | -85.1% | -4.3% | -45.0% | -11.2% | +4.3% | +3.3% | +2.1% | +2.0% | +3,676.9% | |
| – | +341.7% | -51.9% | -62.4% | +205.7% | -24.1% | +46.1% | -44.6% | -40.5% | +434.0% | +81.6% | -45.0% | |
| – | -1.3% | -0.3% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | – | |
| – | -40.0% | -57.4% | +205.1% | -33.6% | -45.5% | -121.2% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16.9% | +0.1% | +5.7% | -5.1% | +0.1% | +0.1% | +0.2% | -98.7% | -0.6% | +3.3% | +40.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.